AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $101.40
- 52-wk low
- $54.15
- Prev close
- $72.13
- Mkt cap
- $11.50B
- P/E
- 22.5x
- Fwd P/E
- 19.3x
Smart money
Earnings
Earnings came in 19.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $769.0M | $826.4M | $759.9M | $789.6M |
| Cost of what it sold | $282.4M | $231.3M | $234.1M | $241.4M |
| Gross profit | $486.7M | $595.1M | $525.8M | $548.2M |
| What it spent | ||||
| Research and development | $38.1M | $73.9M | $36.5M | $36.3M |
| Sales and admin | $313.6M | $318.5M | $297.8M | $286.8M |
| Other operating costs | — | $31.1M | $29.5M | $42.6M |
| Total operating expenses | $351.7M | $423.4M | $363.8M | $365.7M |
| What was left | ||||
| Operating profit | $135.0M | $171.7M | $163.6M | $182.4M |
| Interest on debt | $1.5M | — | $5.4M | — |
| Profit before tax | $144.0M | $174.1M | $157.1M | $189.8M |
| Tax | $25.0M | $33.4M | $32.8M | $38.2M |
| Net profit | $119.0M | $140.6M | $124.3M | $151.6M |
| EBITDA | $215.1M | $244.4M | $226.9M | $189.8M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
6 articles · 7 days
Coverage is mixed
Tone of tracked coverage
Globus Medical Director Stephen T. Zarrilli Executes Stock Options and Sells Shares on August 18, 2026
NeutralAug 20Globus Medical (NYSE: GMED) director exercises options, sells 25,000 shares
NeutralAug 19Is Revenue Growth Amid Margin Pressure Altering The Investment Case For Globus Medical (GMED)?
NeutralAug 17
